A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

著者: John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina, Xinzhong Wang, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Hinrichs, Binyam Bezabeh, Ryan Fleming, Nazzareno Dimasi, Hui Feng, Dorin Toader, Andy Q. Yuan, Lan Xu, Jia Lin, Changshou Gao, Herren Wu, Rakesh Dixit, Jane Osbourn, Steven Coats - Cancer Cell 2016 被引用: 390